Bellerophon Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
13 Oct 23 | SellUS$111,776 | Puissance Capital Management LP | Company | 1,076,841 | US$0.10 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Institutions | 4,517 | 0.0369% |
Individual Insiders | 1,002,650 | 8.2% |
Hedge Funds | 1,026,868 | 8.39% |
General Public | 10,198,613 | 83.4% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,026,868 | US$37.0k | 0% | 100.0% | |||
642,844 | US$23.1k | 0% | no data | |||
196,670 | US$7.1k | 0% | no data | |||
60,913 | US$2.2k | 0% | no data | |||
34,649 | US$1.2k | 0% | no data | |||
25,973 | US$935.0 | 0% | no data | |||
24,705 | US$889.4 | 0% | no data | |||
12,470 | US$448.9 | 0% | no data | |||
4,517 | US$162.6 | 0% | no data | |||
1,723 | US$62.0 | 0% | no data | |||
1,457 | US$52.4 | 0% | no data | |||
1,246 | US$44.9 | 0% | no data |